G. Steven Burrill

An introduction to Burrill Venture Capital

Flash required to view this video. Download the latest version here

 G. Steven Burrill 

News

Biotech takes a beating in market meltdown October 01, 2008 | Press Release

Biotech outperforms market in May June 02, 2008 | Press Release

Biotech Treads Water in April May 01, 2008 | Press Release

  See all News
Sign up to receive email notifications about our upcoming events and news.


Submit a Business Plan

Do great things with us.Click here 
Venture Capital

Burrill Life Sciences III Advisory Board

Paul Berg—Cahill Professor in Biochemistry, Emeritus, Stanford University; Director, Emeritus, Beckman Center for Molecular and Genetic Medicine at Stanford; Nobel Laureate in Chemistry

Carl Feldbaum—President Emeritus, Biotechnology Industry Organization.

Frederick Frank—Vice Chairman and Director, Lehman Brothers.

Martin Gerstel—Chairman of Compugen, Keddem Bioscience and Evogene; Co-Chairman of Itamar Medical; former Co-Chairman and CEO of ALZA Corporation

Lee Hood—President of The Institute for Systems Biology

David M. Lawrence—Chairman and CEO (retired), Kaiser Foundation Health Plan and Hospitals

George Poste—CEO, Health Technology Networks; Director, The Biodesign Institute, Arizona State University; former CSTO and head of R&D, SmithKline Beecham

Tommy Thompson—Former Secretary of Health & Human Services; former Governor of Wisconsin; BLSCF II Advisory Board